Endothelial Nicotinic Acetylcholine Receptors and Angiogenesis

Producción científica: Review articlerevisión exhaustiva

86 Citas (Scopus)

Resumen

Nicotinic acetylcholine receptors (nAChRs) were first described in non-excitable cells just more than a decade ago. The nAChRs on endothelial cells modulate key angiogenic processes, including endothelial cell survival, proliferation, and migration. The receptors may be stimulated by endogenous agonists such as acetylcholine, or exogenous chemicals such as nicotine, to activate physiologic angiogenesis (such as in wound healing) or pathologic angiogenesis (such as retinal neovascularization or tumor angiogenesis). The endothelial nAChRs may represent a target for therapeutic modulation of disorders characterized by insufficient or pathologic angiogenesis.

Idioma originalEnglish (US)
Páginas (desde-hasta)247-253
Número de páginas7
PublicaciónTrends in Cardiovascular Medicine
Volumen18
N.º7
DOI
EstadoPublished - oct 2008
Publicado de forma externa

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Huella

Profundice en los temas de investigación de 'Endothelial Nicotinic Acetylcholine Receptors and Angiogenesis'. En conjunto forman una huella única.

Citar esto